Health Catalyst Inc (HCAT)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $105.09M
Last updated: Nov 17, 2026 at 4:15 PM ET
Health Catalyst Inc (HCAT) Stock Chart
Health Catalyst (HCAT) has a latest price of $1.37 on Nov 17, 2026, 54.7% below its 52-week high of $3.02. Its price fell 39.5% over the past 12 months. The month-end price fell 96.8% over the 5 years through Oct 2026, a compound annual decline of 49.7%.
Price Chart
From Jul 2019 to Oct 2026, its highest month-end close was $58.06 in Jul 2021 and its lowest $1.25 in Apr 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart HCAT with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for HCAT.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 18.9%, and over 6 months it rose 7.9%. The month-end price fell 77.4% over the 3 years through Oct 2026, a compound annual decline of 39.1%.
| Period | Change |
|---|---|
| 1 month | -19.9% |
| 3 months | -18.9% |
| 6 months | +7.9% |
| 12 months | -39.5% |
| 12 months, with dividends | -39.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -77.4% | -39.1% |
| 5 years | -96.8% | -49.7% |
Price by Year
Its best calendar year was 2020, when the price rose 25.4%, and its weakest was 2022, when it fell 73.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.69 | -29.3% |
| 2025 | $2.39 | -66.2% |
| 2024 | $7.07 | -23.7% |
| 2023 | $9.26 | -12.9% |
| 2022 | $10.63 | -73.2% |
| 2021 | $39.62 | -9.0% |
| 2020 | $43.53 | +25.4% |
Trading Range
The price is 18.3% below its 50-day average of $1.68 and 17.9% below its 200-day average of $1.67.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.37 | |
| 52-week high | $3.02 | -54.7% |
| 52-week low | $0.95 | +43.5% |
| 50-day average | $1.68 | -18.3% |
| 200-day average | $1.67 | -17.9% |
Price Risk
Over 3 years, its largest fall from a peak was 91.1%.
| Measure | Value |
|---|---|
| 1-year beta | 1.36 |
| Largest fall, 1 year | -66.7% |
| Largest fall, 3 years | -91.1% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About HCAT
What is HCAT's 1-year price change?
Health Catalyst's price fell 39.5% over the past 12 months. With dividends included, the 12-month total return was -39.5%.
What is HCAT's 5-year price change?
Health Catalyst's month-end price fell 96.8% over the 5 years through Oct 2026, a compound annual decline of 49.7%. These figures leave out dividends.
What is HCAT's 52-week high and low?
Health Catalyst's 52-week high is $3.02 and its 52-week low is $0.95. Its latest price of $1.37 on Nov 17, 2026 is 54.7% below the high.
What is HCAT's beta?
Health Catalyst's 1-year beta against the S&P 500 is 1.36, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 66.7%.
Is the HCAT chart free?
Yes. Advanced Charting for HCAT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
HCAT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors